Akebia Therapeutics, Inc. - Common Stock (AKBA)

CUSIP: 00972D105

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock
Shares outstanding
263,222,327
Total 13F shares
52,161,214
Share change
-5,580,388
Total reported value
$16,491,885
Put/Call ratio
48%
Price per share
$0.32
Number of holders
79
Value change
-$1,812,681
Number of buys
24
Number of sells
46

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AKBA - Akebia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
6.2%
16,259,104
$5,741,000 30 Jun 2022
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
2.8%
7,339,043
$2,592,000 30 Jun 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
2%
5,354,175
$1,891,000 30 Jun 2022
13F
Alerce Investment Management, L.P.
13F
Company
1.8%
4,652,561
$1,642,000 30 Jun 2022
13F
BlackRock Finance, Inc.
13F
Company
1.6%
4,340,026
$1,531,000 30 Jun 2022
13F
FEDERATED HERMES, INC.
13F
Company
0.76%
1,989,467
$702,000 30 Jun 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.61%
1,617,393
$571,000 30 Jun 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.56%
1,482,300
$523,000 30 Jun 2022
13F
HRT FINANCIAL LP
13F
Company
0.42%
1,103,737
$389,000 30 Jun 2022
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.33%
862,168
$304,000 30 Jun 2022
13F
Ergoteles LLC
13F
Company
0.32%
849,000
$300,000 30 Jun 2022
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.3%
782,675
$276,000 30 Jun 2022
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.3%
777,617
$275,000 30 Jun 2022
13F
Violetta Cotreau
3/4/5
SVP, Chief Accounting Officer
class O/S missing
219,954
$268,982 12 May 2022
MORGAN STANLEY
13F
Company
0.25%
655,867
$232,000 30 Jun 2022
13F
FMR LLC
13F
Company
0.24%
621,244
$219,000 30 Jun 2022
13F
Dell J. Faulkingham
3/4/5
SVP, CCO
mixed-class rows
373,841
mixed-class rows
$212,590 28 Feb 2022
Qube Research & Technologies Ltd
13F
Company
0.23%
598,379
$211,000 30 Jun 2022
13F
STATE STREET CORP
13F
Company
0.22%
573,876
$203,000 30 Jun 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.2%
529,450
$187,000 30 Jun 2022
13F
GROUP ONE TRADING LLC
13F
Company
0.18%
467,964
$165,000 30 Jun 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.18%
464,948
$164,000 30 Jun 2022
13F
CITADEL ADVISORS LLC
13F
Company
0.17%
457,303
$162,000 30 Jun 2022
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.16%
414,392
$146,000 30 Jun 2022
13F
Icon Wealth Partners, LLC
13F
Company
0.15%
400,132
$141,000 30 Jun 2022
13F
NORTHERN TRUST CORP
13F
Company
0.14%
360,526
$127,000 30 Jun 2022
13F
Bayesian Capital Management, LP
13F
Company
0.12%
304,100
$107,000 30 Jun 2022
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.11%
301,740
$107,000 30 Jun 2022
13F
Invesco Ltd.
13F
Company
0.1%
264,550
$93,000 30 Jun 2022
13F
Orchard Capital Management, LLC
13F
Company
0.1%
251,826
$89,000 30 Jun 2022
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.1%
250,894
$89,000 30 Jun 2022
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.09%
241,349
$85,000 30 Jun 2022
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.09%
226,770
$80,000 30 Jun 2022
13F
Russell Investments Group, Ltd.
13F
Company
0.09%
225,640
$78,000 30 Jun 2022
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.08%
213,549
$75,000 30 Jun 2022
13F
Michael Thomas Heffernan
3/4/5
Director
mixed-class rows
68,686
mixed-class rows
$59,416 02 Jun 2021
Allspring Global Investments Holdings, LLC
13F
Company
0.06%
168,942
$59,000 30 Jun 2022
13F
JANE STREET GROUP, LLC
13F
Company
0.06%
162,166
$57,000 30 Jun 2022
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.06%
146,708
$52,000 30 Jun 2022
13F
UBS Group AG
13F
Company
0.05%
130,652
$46,000 30 Jun 2022
13F
CITIGROUP INC
13F
Company
0.04%
110,287
$39,000 30 Jun 2022
13F
Parallax Volatility Advisers, L.P.
13F
Company
0.04%
109,683
$39,000 30 Jun 2022
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.03%
90,540
$31,970 30 Jun 2022
13F
FRANKLIN RESOURCES INC
13F
Company
0.03%
82,473
$29,000 30 Jun 2022
13F
Bank of New York Mellon Corp
13F
Company
0.03%
71,836
$26,000 30 Jun 2022
13F
LMR Partners LLP
13F
Company
0.02%
64,849
$23,000 30 Jun 2022
13F
EDMOND DE ROTHSCHILD HOLDING S.A.
13F
Company
0.02%
50,000
$18,000 30 Jun 2022
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.02%
47,100
$17,000 30 Jun 2022
13F
HighTower Advisors, LLC
13F
Company
0.02%
45,724
$16,000 30 Jun 2022
13F
MACKENZIE FINANCIAL CORP
13F
Company
0.02%
42,792
$15,000 30 Jun 2022
13F

Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q3 2022

As of 30 Sep 2022, Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,161,214 shares. The largest 10 holders included VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, Alerce Investment Management, L.P., BlackRock Inc., MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, FEDERATED HERMES, INC., GEODE CAPITAL MANAGEMENT, LLC, and DIMENSIONAL FUND ADVISORS LP. This page lists 79 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
82
Q3 2022 holders
79
Holder diff
-3
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 Value $ Q3 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.